Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia
Clinical trial NCT02538614 · TERMINATED
Trial details
- NCT number
- NCT02538614
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-29
- Primary completion
- 2017-07-05
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.